Matheus H W Crommentuijn
Overview
Explore the profile of Matheus H W Crommentuijn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
663
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dusoswa S, Verhoeff J, van Asten S, Lubbers J, van den Braber M, Peters S, et al.
Front Immunol
. 2024 Feb;
15:1343484.
PMID: 38318180
Background: Glioblastomas manipulate the immune system both locally and systemically, yet, glioblastoma-associated changes in peripheral blood immune composition are poorly studied. Age and dexamethasone administration in glioblastoma patients have been...
2.
Rodriguez E, Boelaars K, Brown K, Li R, Kruijssen L, Bruijns S, et al.
Nat Commun
. 2021 Feb;
12(1):1270.
PMID: 33627655
Changes in glycosylation during tumour progression are a key hallmark of cancer. One of the glycan moieties generally overexpressed in cancer are sialic acids, which can induce immunomodulatory properties via...
3.
Schetters S, Kruijssen L, Crommentuijn M, Kalay H, den Haan J, van Kooyk Y
FASEB J
. 2021 Jan;
34(9):12406-12418.
PMID: 33411367
The clinically successful adjuvant MF59 is used in seasonal influenza vaccines, which is proposed to enhance immunity by creating an immune-competent microenvironment in the muscle that allows recruitment of immune...
4.
Schetters S, Rodriguez E, Kruijssen L, Crommentuijn M, Boon L, Van den Bossche J, et al.
J Immunother Cancer
. 2020 Jul;
8(2).
PMID: 32690667
Background: PD1 immune checkpoint blockade (αPD1 ICB) has shown unparalleled success in treating many types of cancer. However, response to treatment does not always lead to tumor rejection. While αPD1...
5.
Crommentuijn M, Schetters S, Dusoswa S, Kruijssen L, Garcia-Vallejo J, van Kooyk Y
J Immunother Cancer
. 2020 Apr;
8(1).
PMID: 32303613
Background: Glioblastoma (GBM) is the most common and deadliest form of brain cancer in adults. Standard treatment, consisting of surgery and radiochemotherapy, only provides a modest survival benefit and is...
6.
Schetters S, Kruijssen L, Crommentuijn M, Kalay H, Ochando J, den Haan J, et al.
Front Immunol
. 2018 Jun;
9:990.
PMID: 29867967
The efficacy of vaccination studies aimed at targeting antigens to human DC-SIGN (hDC-SIGN) have been notoriously difficult to study , as eight dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN)...
7.
Berenguer J, Lagerweij T, Zhao X, Dusoswa S, van der Stoop P, Westerman B, et al.
J Extracell Vesicles
. 2018 Apr;
7(1):1446660.
PMID: 29696074
Cancer cells release extracellular vesicles (EVs) that contain functional biomolecules such as RNA and proteins. EVs are transferred to recipient cancer cells and can promote tumour progression and therapy resistance....
8.
Lagerweij T, Hiddingh L, Biesmans D, Crommentuijn M, Cloos J, Li X, et al.
Oncotarget
. 2016 Mar;
7(24):35776-35788.
PMID: 26967057
Treatment of medulloblastoma in children fails in approximately 30% of patients, and is often accompanied by severe late sequelae. Therefore, more effective drugs are needed that spare normal tissue and...
9.
Crommentuijn M, Maguire C, Niers J, Vandertop W, Badr C, Wurdinger T, et al.
Mol Oncol
. 2015 Dec;
10(4):625-34.
PMID: 26708508
Glioblastoma (GBM) is the most common malignant brain tumor in adults. We designed an adeno-associated virus (AAV) vector for intracranial delivery of secreted, soluble tumor necrosis factor-related apoptosis-inducing ligand (sTRAIL)...
10.
van der Vos K, Abels E, Zhang X, Lai C, Carrizosa E, Oakley D, et al.
Neuro Oncol
. 2015 Oct;
18(1):58-69.
PMID: 26433199
Background: To understand the ability of gliomas to manipulate their microenvironment, we visualized the transfer of vesicles and the effects of tumor-released extracellular RNA on the phenotype of microglia in...